Conditions: Recurrent Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Pembrolizumab; Drug: Epacadostat; Drug: Cetuximab; Drug: Cisplatin; Drug: Carboplatin; Drug: 5-Fluorouracil
Sponsors: Incyte Corporation; Merck Sharp & Dohme Corp.
Not yet recruiting
from #ORL via a.lsfakia on Inoreader http://ift.tt/2isbzDC
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου